since there is substantial evidence for a nigrostriatal dopamine defect in parkinson 's disease and since monoamine oxidase ( mao ) appears to be essential for the degradation of dopamine , we investigated whether this enzyme is involved in the pathogenesis of this disease or in the therapeutic action of l-dopa .
C0030567
parkinson 's disease
C0023570
l-dopa